Raagbp Pharmaceuticals Private Limited

Provides healthcare services through a registered office in Delhi since 2019.

2019 | Delhi (India) | Active
Last Updated:

Raagbp Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 1.02 M
  • Company Age 5 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.18 Cr
  • Satisfied Charges ₹ 3.85 Cr
  • Revenue Growth 369.33%
  • Profit Growth 2421.09%
  • Ebitda 3710.89%
  • Net Worth 287.20%
  • Total Assets 111.81%

About Raagbp Pharmaceuticals

Raagbp Pharmaceuticals Private Limited (RPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 01 October 2019 (Five years and five months 0 days old ). Its registered office is in Delhi, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.02 M.

The company currently has active open charges totaling ₹4.18 Cr. The company has closed loans amounting to ₹3.85 Cr, as per Ministry of Corporate Affairs (MCA) records.

Rama Goyal and Avinash Goyal serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230DL2019PTC355706

  • Company No.

    355706

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    01 Oct 2019

  • Date of AGM

    27 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Healthcare

Who are the key members and board of directors at Raagbp Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Rama Goyal Country flag representing In Director 01-Oct-2019Current
Avinash Goyal Country flag representing In Director 01-Oct-2019Current

Financial Performance of Raagbp Pharmaceuticals.

Raagbp Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 369.33% increase. The company also saw a substantial improvement in profitability, with a 2421.09% increase in profit. The company's net worth Soared by an impressive increase of 287.2%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
369.33%
Revenue from Operations
369.33%
Total Assets
111.81%
Profit or Loss
2421.09%
Net Worth
287.20%
EBITDA
3710.89%

What is the Ownership and Shareholding Structure of Raagbp Pharmaceuticals?

In 2021, Raagbp Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹41.80 M

Satisfied Charges

₹38.50 M

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 4.18 Cr

Latest Charge Details

DateLenderAmountStatus
16 Jul 2024Axis Bank Limited₹4.18 CrOpen
17 Nov 2022Canara Bank₹3.85 CrSatisfied

How Many Employees Work at Raagbp Pharmaceuticals?

Unlock and access historical data on people associated with Raagbp Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Raagbp Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raagbp Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Raagbp Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Raagbp Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.

    27 Sep 2024

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 41.80 M with Charge ID 100977060 was registered on 16 Jul 2024.

    16 Jul 2024

  • Balance Sheet

    Raagbp Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

    31 Mar 2024

  • Charges

    A charge registered on 17 Nov 2022 via Charge ID 100684198 with Canara Bank was fully satisfied on 30 Nov 2023.

    30 Nov 2023

  • Charges

    A charge with Canara Bank amounted to Rs. 38.50 M with Charge ID 100684198 was registered on 17 Nov 2022.

    17 Nov 2022

  • Director Appointment

    Rama Kant Goyal was appointed as a Director was appointed as a Director on 01 Oct 2019 & has been associated with this company since 5 years 5 months .

    01 Oct 2019

Frequently asked questions

  • What is the Incorporation or founding date of Raagbp Pharmaceuticals Private Limited?

    Raagbp Pharmaceuticals Private Limited was incorporated on 01 Oct 2019.

  • What is authorized share capital and paid-up capital of Raagbp Pharmaceuticals Private Limited?

    The authorized share capital of Raagbp Pharmaceuticals Private Limited is ₹ 3.00 M and paid-up capital is ₹ 1.02 M.

  • Who are the current board members & directors of Raagbp Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Raagbp Pharmaceuticals Private Limited.

    • Rama Kant Goyal
    • Avinash Goyal
  • What is the registered address of Raagbp Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Raagbp Pharmaceuticals Private Limited is H No.2027-B Pvt-2027/156 Plot No Old-124 -125 Kh.No 243 Ground Floor Ganeshpura-B India, Delhi, 110035.

  • What is the corporate identification number (CIN) and company number of Raagbp Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Raagbp Pharmaceuticals Private Limited is U24230DL2019PTC355706 and the company number is 355706 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Raagbp Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Raagbp Pharmaceuticals Private Limited has risen by 369.33%.

  • What change has been observed in the net worth of Raagbp Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Raagbp Pharmaceuticals Private Limited has experienced an upsurge of 287.20%.

  • What are the total open charges for Raagbp Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Raagbp Pharmaceuticals Private Limited amount to ₹ 4.18 Cr.

  • When was the last Balance Sheet of Raagbp Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Raagbp Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.